BAROLLO, SUSI
 Distribuzione geografica
Continente #
NA - Nord America 5.672
EU - Europa 1.066
AS - Asia 512
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
SA - Sud America 1
Totale 7.258
Nazione #
US - Stati Uniti d'America 5.669
IT - Italia 576
CN - Cina 455
SE - Svezia 128
FI - Finlandia 107
DE - Germania 99
GB - Regno Unito 72
VN - Vietnam 36
IE - Irlanda 25
UA - Ucraina 18
FR - Francia 15
IN - India 8
HK - Hong Kong 6
NL - Olanda 6
BE - Belgio 4
EU - Europa 4
AT - Austria 3
CA - Canada 3
PL - Polonia 3
RU - Federazione Russa 3
AL - Albania 2
CZ - Repubblica Ceca 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TR - Turchia 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
IQ - Iraq 1
JP - Giappone 1
PH - Filippine 1
SG - Singapore 1
TW - Taiwan 1
Totale 7.258
Città #
Fairfield 1.060
Woodbridge 587
Chandler 526
Ashburn 468
Houston 404
Ann Arbor 378
Cambridge 375
Seattle 365
Wilmington 340
Beijing 133
Padova 117
San Diego 107
Princeton 95
Medford 78
Jacksonville 69
Des Moines 65
Helsinki 53
Nanjing 49
Boardman 48
Roxbury 43
Dong Ket 36
Milan 33
Dublin 25
Rome 24
Nanchang 21
Columbus 19
Jinan 19
Washington 19
Changsha 18
London 18
New York 18
Falls Church 16
Shenyang 16
Tianjin 16
Hebei 14
Ogden 14
Guangzhou 13
Hefei 11
Norwalk 11
Redwood City 11
Jiaxing 9
Kunming 9
Kilburn 8
Bari 7
Catania 7
Dearborn 7
Fuzhou 7
Kharkiv 7
Phoenix 7
Taizhou 7
Zhengzhou 7
Bologna 6
Cagliari 6
Haikou 6
Hangzhou 6
Hong Kong 6
Naples 6
Tappahannock 6
Turin 6
Vigonza 6
Florence 5
Taiyuan 5
Anagni 4
Borås 4
Caserta 4
Chiswick 4
Hounslow 4
Munich 4
Paris 4
Rockville 4
Trieste 4
Venice 4
Castelbellino 3
Cesiomaggiore 3
Crevacuore 3
Formia 3
Indiana 3
Livorno 3
Marghera 3
Martellago 3
Montemesola 3
Ningbo 3
Nürnberg 3
Palermo 3
Pune 3
Verona 3
Vienna 3
Aprilia 2
Auckland 2
Benevento 2
Berlin 2
Brentwood 2
Brescia 2
Bucine 2
Casale Monferrato 2
Casteggio 2
Castellammare di Stabia 2
Cernusco sul Naviglio 2
Chengdu 2
Dallas 2
Totale 5.989
Nome #
L’elastosonografia come sostituto dell’esame citologico nei nodi soffici 258
PROGNOSTIC SIGNIFICANCE OF TERT PROMOTER AND BRAF MUTATIONS IN TIR-4 AND TIR-5 THYROID CYTOLOGY 228
The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes 193
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. 185
Nuovo approccio nel trattamento del carcinoma midollare tiroideo 161
Overexpression of L-Type amino acid transporter 1 (LAT1) and 2 (LAT2): Novel markers of neuroendocrine tumors 148
BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience 142
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 139
Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients 138
Effects of point mutations in the binding pocket of the mouse major urinary protein MUP20 on ligand affinity and specificity 135
The PDCD4/miR-21 pathway in medullary thyroid carcinoma. 134
Prevalence, Tumorigenic Role, and Biochemical Implications of Rare BRAF Alterations. 133
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines 131
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 125
Functional Significance of the Novel H-RAS Gene Mutation M72I in a Patient with Medullary Thyroid Cancer. 119
MEN2A/FMTC AND THE V804M RET MUTATION 112
Iodine status in schoolchildren living in northeast italy:the importance of iodized-salt use and milk consumption. 110
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 109
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 108
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake 107
Calcitonin measurement and immunoassay interference: A case report and literature review 106
Efficacy of educational intervention to improve awareness of the importance of iodine, use of iodized salt, and dietary iodine intake in northeastern Italian schoolchildren 104
Iodine status from childhood to adulthood in females living in North-East Italy: Iodine deficiency is still an issue. 103
EF24 (a curcumin analog) and ZSTK474 emphasizes the effect of cabozantinib in medullary thyroid cancer 102
microRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. 99
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma 98
Addison's disease: a survey on 633 patients in Padova. 97
INFLUENCE OF PHYSIOLOGICAL DIETARY SELENIUM SUPPLEMENTATION ON THE NATURAL COURSEOF AUTOIMMUNE THYROIDITIS 94
RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series 94
Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience. 93
Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors. 93
The effects of iodine supplementation in pregnancy on iodine status, thyroglobulin levels and thyroid function parameters: Results from a randomized controlled clinical trial in a mild-to-moderate iodine deficiency area 93
Frequency and significance of Ras, Tert promoter, and Braf mutations in cytologically indeterminate thyroid nodules: A monocentric case series at a tertiary-level Endocrinology unit 92
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line 91
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. 91
Biological effects of EF24, a curcumin derivative, alone or combined with mitotane in adrenocortical tumor cell lines 91
Le malattie autoimmuni della tiroide nei pazienti affetti da Sindrome Poliendocrina Autoimmune di tipo 1 (SPA-1) 90
BRAF in primary and recurrent papillary thyroid cancers the relationship with (131) 1 and 2 [(18)F] fluoro-2-deoxy-D-glucose uptake ability. 89
Deregulated expression of aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients. 88
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 85
Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients 85
Deregulated expression of VHL mRNA variants in papillary thyroid cancer 83
A Novel Thyroid Hormone Receptor Beta Mutation (G357R) in a Family with Resistance to Thyroid Hormone Beta: Extending the Borders of the "Hot" Region in the THRB Gene 83
The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways. 81
Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models 78
PDCD4 expression in thyroid neoplasia 76
Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity? 76
The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells. 75
High Expression of the Urokinase Plasminogen Activator and Its Cognate Receptor Associates with Advanced Stages and Reduced Disease-Free Interval in Papillary Thyroid Carcinoma. 74
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. 74
Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation 72
MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome 72
Amiodarone-induced thyrotoxicosis: Differential diagnosis using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR) 72
Evidence of a low prevalence of a ras mutations in a large medullary thyroid cancer series. 70
Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer 70
Comparison Of The Diagnostic Accuracy Of Combined Elastosonography And Braf Analysis Versus Cytology And Ultrasonography For Thyroid Nodule Suspected Of Malignancy. 69
In papillary thyroid carcinoma BRAF(V600E) is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval. 68
CTLA-4 and PD-1 ligand gene expression in epithelial thyroid cancers 68
Assieme ago ipodermico con dispositivo di sicurezza 63
Galectin-3 expression in thyroid fine needle cytology (t-FNAC) uncertain cases: Validation of molecular markers and technology innovation 63
RET codon 609 mutations: a contribution for better clinical managing 62
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: report of seven additional sicilian patients and overview of the overall series from sicily. 62
Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT. 56
Iodine status in pregnancy: role of dietary habits and geographical origin 53
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma 53
Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden 49
Autoimmune polyglandular syndrome type 1 in italy: a survey of 114 patients 46
Case report: malignant pheochromocytoma in MEN 1. 45
The role of the size in thyroid cancer risk stratification 44
Addison's disease: A survey on 633 patients in Padova 44
Case report: malignant pheochromocytoma in MEN 1 41
Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma 41
Changing dietary habits in veneto region over two decades: Still a long road to go to reach an iodine-sufficient status 41
The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings 38
Calcium/Calmodulin-Dependent Protein Kinase II and Its Endogenous Inhibitor α in Medullary Thyroid Cancer. 37
Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications 35
Autoantibodies to interferon-omega in patients with autoimmune polyendocrine syndrome type 1 34
Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows 34
Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up? 33
The role of RET genotypes as modifier loci for sporadic medullary thyroid cancer 32
Expression and clinical utility of transcription factors involved in epithelial–mesenchymal transition during thyroid cancer progression 26
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling 23
Effects of Handroanthus impetiginosus (Mart. ex DC.) Mattos extract on inflammatory, immune, atherogenic profile and differentiation in THP-1 cell line 21
Validità diagnostica degli indici di elasticità dei nodi tiroidei: dati preliminari 21
PAPILLARY THYROID CANCER IS CHARACTERIZED BY ALTERED EXPRESSION OF GENES INVOLVED IN THE SUMOYLATION PROCESS 19
Altered B cell homeostasis and Toll-like receptor 9-driven response in patients affected by autoimmune polyglandular syndrome Type 1: Altered B cell phenotype and dysregulation of the B cell function in APECED patients 19
Selective inhibitors of aurora kinases inhibit proliferation, reduce cell viability and impair cell cycle progression in papillary thyroid carcinoma cells 17
Circulating miR-146a predicts glucocorticoid response in thyroid eye disease 9
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines 8
Biological activities of the aerial and undergound parts of Gymnadenia nigra Rchb.f. (syn. Nigritella nigra (L.) Rchb. f.) from the Italian Alps 8
A Novel TSH Receptor Gene Variant Associated With Non-Autoimmune Hyperthyrotropinemia: a Case Report 7
Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers 7
Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma 5
Calcitonin levels in autoimmune atrophic gastritis-related hypergastrinemia 5
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures 2
Totale 7.357
Categoria #
all - tutte 24.221
article - articoli 22.439
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 170
selected - selezionate 0
volume - volumi 0
Totale 46.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019487 0 0 0 0 0 0 0 0 6 106 179 196
2019/20201.773 161 81 71 234 156 102 196 175 231 208 91 67
2020/20211.222 68 110 50 98 35 66 52 92 134 220 110 187
2021/20221.298 49 135 136 96 105 77 77 123 95 39 97 269
2022/20231.104 195 150 19 153 166 136 10 70 121 15 53 16
2023/2024719 33 80 110 84 83 101 109 81 38 0 0 0
Totale 7.357